CVE-2025-61940

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest...

CVE-2025-61940

NMIS/BioDose (versions before V22.02) uses a common SQL Server user account for database access, while the client app performs password authentication but the underlying DB connection maintains access. The latest release adds Windows authentication to the database, which would restrict the connec...

CVE-2025-61940 Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest...

PT-2025-48777

Name of the Vulnerable Software and Affected Versions NMIS/BioDose versions prior to V22.02 Description NMIS/BioDose versions prior to V22.02 utilize a shared SQL Server user account for database access. Client application user access is controlled by password authentication within the client...